Pulmonary Embolism Summary

Networked: 7849 relevant articles (429 outcomes, 731 trials/studies) for this Disease

Key Drugs and Agents for Pulmonary Embolism

1. Heparin (Liquaemin) : 77 outcomes 94 studies in 759 results : FDA 74 Generic
   
2. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight) : 40 outcomes 61 studies in 329 results : IBA
   
3. fibrin fragment D (D-dimer) : 21 outcomes 77 studies in 556 results : IBA
   
4. Warfarin (Coumadin) : 20 outcomes 27 studies in 200 results : FDA 21 Generic
   
5. Enoxaparin (Lovenox) : 18 outcomes 30 studies in 119 results : FDA 2 Generic
   
6. Anticoagulants : 15 outcomes 16 studies in 217 results : IBA
   
7. 4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acid : 12 outcomes 35 studies in 213 results : IBA
   
8. Tissue Plasminogen Activator (Alteplase) : 12 outcomes 26 studies in 181 results : FDA 2
   
9. Streptokinase : 12 outcomes 13 studies in 126 results : FDA 1
   
10. Adenosine Diphosphate (ADP) : 12 outcomes 3 studies in 15 results : IBA
    

Diseases Related to Pulmonary Embolism

1. Venous Thrombosis (Deep-Vein Thrombosis)
2. Thrombosis (Thrombus)
3. Hemorrhage
4. Myocardial Infarction
5. Venous Thromboembolism

Key Therapies for Pulmonary Embolism

1. Thrombolytic Therapy : 35 outcomes 27 studies in 448 results
   
2. Vena Cava Filters (Inferior Vena Cava Filter) : 33 outcomes 16 studies in 316 results
   
3. Catheters : 18 outcomes 19 studies in 376 results
   
4. Embolectomy : 16 outcomes 8 studies in 292 results
   
5. Thrombectomy : 13 outcomes 5 studies in 131 results